SEARCH

SEARCH BY CITATION

  • 1
    Cotter SM. Autoimmune hemolytic anemia in dogs. Comp Cont Educ 1992;14:5359.
  • 2
    Klag AR. Hemolytic anemia in dogs. Comp Cont Educ 1992; 14:10901098.
  • 3
    Klag AR, Giger U. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986–1990). J Am Vet Med Assoc 1993; 202:783788.
  • 4
    Stewart AF, Feldman BF. Immune-mediated hemolytic anemia: Part II. clinical entity, diagnosis, and treatment theory. Comp Cont Educ. 1993; 15: 14791491.
  • 5
    Collins PW, Newland AC. Treatment modalities of autoimmune blood disorders. Semin Hematol 1992;29:6474.
  • 6
    Klein MK, Dow SW, Rosychuk RAW. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982–1987). J Am Vet Med Assoc 1990;195:246250.
  • 7
    Blanchette V., Imbach P., Andrew M., et al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703707.
  • 8
    Engelfreit CP, Overbeeke MAM, Kr von dem Borne AEG. Autoimmune hemolytic anemia. Semin Hematol 1992;6:206213.
  • 9
    Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med 1990; 112:278292.
  • 10
    Sacher RA. Intravenous gammaglobulin therapy: current role in bone marrow transplant, malignancy, and immune hematologic disorders. Semin Hematol 1992;29 (suppl 2): 15.
  • 11
    Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol 1992; 29 (suppl 2): 7282.
  • 12
    Gelfand EW. Treatment of autoimmune diseases with intravenous gammaglobulin. Semin Hematol 1992;29 (suppl 2): 127133.
  • 13
    Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107116.
  • 14
    Flores G., Cunningham-Rundles C., Newland AC, et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol. 1993; 44: 237242.
  • 15
    Basta M., Kirshborn P., Frank MM, et al. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin: attenuation of acute, complement-dependent immune damage in a guinea pig model. J Clin Invest 1989;84:19741981.
  • 16
    Ling ZD, Yeoh E., Webb B., et al. Intravenous immunoglobulin induces interferon gamma and interleukin-6 in vivo. J Clin Immunol 1993;13:302309.
  • 17
    Toyoda M., Zhang X., Petrosian A., et al. Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. J Clin Immunol 1994;14:178189.
  • 18
    Basta M., Fries LF, Frank MM. High doses of intravenous Iginhibit in vitro uptake of C4 fragments onto sensitized erythrocytes. Blood 1991;77:376380.
  • 19
    Kondo N., Ozawa T., Mushiake K., et al. Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J Clin Immunol 1991;11:152158.
  • 20
    Ballow M. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases. Cancer 1991;68:14301436.
  • 21
    Reagan WJ, Scott-Montcrief JC, Snyder PW, et al. Action of human intravenous gamma globulin on the canine hematopoietic system. Blood 1994; 84 (suppl): 662a.
  • 22
    Scott-Montcreif JC, Reagan WJ, Glickman LT, et al. Treatment of nonregenerative anemia with human gamma-globulin in dogs. J Am Vet Med Assoc 1995;206:18951900.
  • 23
    Misbah SA, Chapel HM. Adverse effects of intravenous immunoglobulin. Drug Saf 1993;9:254262.